60 DEGREES PHARMACEUTICALS, INC.: operating_income
| Value | {"amount": -9715181, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | 60 DEGREES PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:58:51.297335+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/414c9982-85cf-45d6-89db-79a49d5f39e4
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001554855-26-000467Retrieved: 2026-08-19T18:58:51.297335+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001946563/operating-income/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/414c9982-85cf-45d6-89db-79a49d5f39e4
History
- supersedes {"amount": -9714931, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} (evidence 0001013762-25-003343)